StonvexLoading…
StonvexCore line items from RYAAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | €13.95B | €13.44B | €10.78B | €4.80B |
Operating Income | €1.56B | €2.06B | €1.44B | €-339.60M |
Net Income | €1.61B | €1.92B | €1.31B | €-240.80M |
EPS (Diluted) | €1.45 | €1.67 | €1.15 | €-0.21 |
Total Assets | €17.51B | €17.18B | €16.41B | €15.15B |
Total Liabilities | Not available | €9.56B | €10.76B | Not available |
Cash & Equivalents | €3.86B | €3.88B | €3.60B | €2.67B |
Free Cash Flow OCF − CapEx | €1.86B | €766.00M | €1.98B | €758.90M |
Shares Outstanding | Not available | Not available | Not available | Not available |